4//SEC Filing
Berenson Stephen 4
Accession 0000899243-21-024998
CIK 0001609809other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:30 PM ET
Size
5.4 KB
Accession
0000899243-21-024998
Insider Transaction Report
Form 4
Berenson Stephen
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-16+23,000→ 23,000 totalExercise: $19.74Exp: 2031-06-15→ Common Stock (23,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 16, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001760671
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:30 PM ET
- Size
- 5.4 KB